Gli antivirali molnupiravir o nirmatrelvir-ritonavir riducono la probabilità di ricovero e di decess...
Gli antivirali molnupiravir o nirmatrelvir-ritonavir riducono la probabilità di ricovero e di decesso nei pazienti immunocompromessi con Covid-19
About this item
Full title
Author / Creator
Publisher
Rome: Pensiero Scientifico Editore
Journal title
Language
Italian
Formats
Publication information
Publisher
Rome: Pensiero Scientifico Editore
Subjects
More information
Scope and Contents
Contents
Characteristics and outcomes of US veterans with immunocompromised conditions at high risk of SARS-CoV-2 infection with or without receipt of oral antiviral agents. The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants. Identifying veterans who benefi...
Alternative Titles
Full title
Gli antivirali molnupiravir o nirmatrelvir-ritonavir riducono la probabilità di ricovero e di decesso nei pazienti immunocompromessi con Covid-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3174415755
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3174415755
Other Identifiers
ISSN
0034-1193
E-ISSN
2038-1840
DOI
10.1701/4334.43179
